
Sign up to save your podcasts
Or


With a focus on improving access and modernizing surgical techniques, this episode covers how the hepatic artery infusion (HAI) pump is transforming the landscape for patients with liver-directed malignancies in Kentucky.
Host Dr. Zach Pulliam, Medical Oncology Fellow at University of Louisville, speaks with expert Dr. Michael Cavnar from the University of Kentucky Markey Cancer Center to discuss the history, clinical benefits, and new accessibility trials for HAI pump therapy.
The conversation focuses on the logistics of rural cancer care, survival benefits for colorectal liver metastases and cholangiocarcinoma, and the future of home-based chemotherapy infusion.
Host: Zach Pulliam, MD,
Guest: Michael Cavnar, MD
The Kentucky Society of Clinical Oncology (KYSCO)
By Kentucky Society of Clinical Oncology (KYSCO)With a focus on improving access and modernizing surgical techniques, this episode covers how the hepatic artery infusion (HAI) pump is transforming the landscape for patients with liver-directed malignancies in Kentucky.
Host Dr. Zach Pulliam, Medical Oncology Fellow at University of Louisville, speaks with expert Dr. Michael Cavnar from the University of Kentucky Markey Cancer Center to discuss the history, clinical benefits, and new accessibility trials for HAI pump therapy.
The conversation focuses on the logistics of rural cancer care, survival benefits for colorectal liver metastases and cholangiocarcinoma, and the future of home-based chemotherapy infusion.
Host: Zach Pulliam, MD,
Guest: Michael Cavnar, MD
The Kentucky Society of Clinical Oncology (KYSCO)